We enable nucleic acid labeling bioconjugation

Uncategorized

  • 16
    Jan

    We welcome the opportunity to meet you at LS2 annual Meeting 2024.

        At the LS2 Annual Meeting 2024, you would surely like to listen to the presentation of our Managing Director Dr. Thomas Frischmuth on

    MORE →
  • 18
    Dec

    The year 2023 in Retrospect

        In the final days of the year, the baseclick team would like to look back on 2023. We personally thank all our customers,

    MORE →
  • 22
    Aug

    Find out more about the latest RNA drug development

    22.08.2023 Munich’s leading researchers have preclinically evaluated an active RNA Drug called RCS-21 to prevent severe pneumonia and fibrosis, caused by infections such as SARS-CoV2

    MORE →
  • 25
    May

    baseclick designs next-generation adapted ingredients

    Neuried, Munich Mai 25, 2023 baseclick indicates new dimensions to approach nucleic acid-based therapies, in association with the Cluster for Nucleic Acid Therapeutics Munich (CNATM)

    MORE →
  • 1
    May

    15th Anniversary of baseclick

    We celebrate the 15th anniversary of baseclick’s innovations and we are offering a discount of up to 15%. Every year in April we celebrate the

    MORE →